YU79693A - Inhibitori hiv proteaze korisni za lečenje aidsa-a - Google Patents

Inhibitori hiv proteaze korisni za lečenje aidsa-a

Info

Publication number
YU79693A
YU79693A YU79693A YU79693A YU79693A YU 79693 A YU79693 A YU 79693A YU 79693 A YU79693 A YU 79693A YU 79693 A YU79693 A YU 79693A YU 79693 A YU79693 A YU 79693A
Authority
YU
Yugoslavia
Prior art keywords
hiv
treatment
methods
pharmaceutically acceptable
aids
Prior art date
Application number
YU79693A
Other languages
English (en)
Inventor
J.E. Fritz
M. Hammod
S.W. Kaldor
Original Assignee
Eli Lilly And Co Corp. Center Indianapolis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co Corp. Center Indianapolis filed Critical Eli Lilly And Co Corp. Center Indianapolis
Publication of YU79693A publication Critical patent/YU79693A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

INHIBITORI HIV PROTEAZE KORISNI ZA LEČENJE AIDSA-A, opisana su jedinjenja koja inhibiraju proteazu Sifrovanu HIV virus ima tipa HIV-1 ili HIV-2, i koja su korisna u lečenju i prevenciji infekcije HIV-om i lečenju i prevenciji AIDS-a. Prikazani su postupci za dobijanje jedinjenja ili farВ­maceutski prihvadjivih soli tin jedinjenja i primeri sinteza. Takodje su opisani postupci za lečenje ili prevenciju AIDS-a, postupci za lečenje ili prevenciju infekcije HIV-om i postupci inhibiranja HIV replikacije. Kroz opis formulacija prikazane su moguće varijante davanja preparata, kao i njihov sastav, uključujući aktivni sastojak (jedinjenje I ili farmaceutski prih-vadjiva so tog jedinjenja), farmaceutski prihvatljive nosače, razblaživače, i vezivna sredstva.
YU79693A 1992-12-22 1993-12-20 Inhibitori hiv proteaze korisni za lečenje aidsa-a YU79693A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/994,871 US5434265A (en) 1992-12-22 1992-12-22 Inhibitors of HIV protease

Publications (1)

Publication Number Publication Date
YU79693A true YU79693A (sh) 1997-07-31

Family

ID=25541167

Family Applications (1)

Application Number Title Priority Date Filing Date
YU79693A YU79693A (sh) 1992-12-22 1993-12-20 Inhibitori hiv proteaze korisni za lečenje aidsa-a

Country Status (24)

Country Link
US (2) US5434265A (sh)
EP (1) EP0604183B1 (sh)
JP (1) JPH07179417A (sh)
KR (1) KR940014335A (sh)
CN (1) CN1098407A (sh)
AT (1) ATE149488T1 (sh)
AU (1) AU667593B2 (sh)
BR (1) BR9305164A (sh)
CA (1) CA2112041A1 (sh)
CZ (1) CZ281693A3 (sh)
DE (1) DE69308514T2 (sh)
DK (1) DK0604183T3 (sh)
ES (1) ES2101252T3 (sh)
FI (1) FI935777A (sh)
GR (1) GR3023457T3 (sh)
HU (1) HUT70748A (sh)
IL (1) IL108091A (sh)
MX (1) MX9308005A (sh)
NO (1) NO301005B1 (sh)
NZ (1) NZ250492A (sh)
PL (1) PL301576A1 (sh)
TW (1) TW280813B (sh)
YU (1) YU79693A (sh)
ZA (1) ZA939476B (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5679688A (en) 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
DE4439193A1 (de) * 1994-11-03 1996-05-09 Bayer Ag Mischung zur Korrosionshemmung von Metallen
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
KR100490807B1 (ko) * 1995-11-28 2005-10-14 세파론, 인코포레이티드 시스테인및세린프로테아제의d-아미노산함유억제제
KR19980703369A (ko) * 1996-01-29 1998-10-15 후루따 다께시 카르보닐 화합물의 환원 방법
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
EP0900566A4 (en) 1996-12-27 2001-04-25 Japan Energy Corp NEW TRIPEPTIDE COMPOUNDS AND MEDICINES AGAINST AIDS
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US6096778A (en) * 1997-10-07 2000-08-01 Cephalon, Inc. α-ketoamide multicatalytic protease inhibitors
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
US6150378A (en) * 1997-10-07 2000-11-21 Cephalon, Inc. Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
EP1095022A1 (en) * 1998-07-08 2001-05-02 G.D. Searle & Co. Retroviral protease inhibitors
EP1954685A4 (en) * 2005-11-16 2009-11-11 Nitromed Inc FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
EP0361341A3 (en) * 1988-09-28 1991-07-03 Miles Inc. Therapeutics for aids based on inhibitors of hiv protease
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
EP0558603B1 (en) * 1990-11-19 1998-08-26 Monsanto Company Retroviral protease inhibitors
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
US5516784A (en) * 1991-08-13 1996-05-14 Schering Corporation Anti-HIV (AIDS) agents
US5491166A (en) * 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS

Also Published As

Publication number Publication date
ES2101252T3 (es) 1997-07-01
US5514802A (en) 1996-05-07
ZA939476B (en) 1995-06-19
US5434265A (en) 1995-07-18
NO301005B1 (no) 1997-09-01
HU9303680D0 (en) 1994-04-28
MX9308005A (es) 1994-08-31
DE69308514T2 (de) 1997-07-10
PL301576A1 (en) 1994-06-27
BR9305164A (pt) 1994-11-01
EP0604183A1 (en) 1994-06-29
CZ281693A3 (en) 1994-07-13
FI935777A (fi) 1994-06-23
CA2112041A1 (en) 1994-06-23
AU667593B2 (en) 1996-03-28
AU5253093A (en) 1994-07-07
CN1098407A (zh) 1995-02-08
NO934718L (no) 1994-06-23
KR940014335A (ko) 1994-07-18
HUT70748A (en) 1995-10-30
NO934718D0 (no) 1993-12-20
EP0604183B1 (en) 1997-03-05
IL108091A (en) 1998-04-05
ATE149488T1 (de) 1997-03-15
DK0604183T3 (da) 1997-05-26
TW280813B (sh) 1996-07-11
JPH07179417A (ja) 1995-07-18
NZ250492A (en) 1995-08-28
DE69308514D1 (de) 1997-04-10
IL108091A0 (en) 1994-04-12
GR3023457T3 (en) 1997-08-29
FI935777A0 (fi) 1993-12-21

Similar Documents

Publication Publication Date Title
YU79693A (sh) Inhibitori hiv proteaze korisni za lečenje aidsa-a
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
ATE175412T1 (de) Hiv-protease-inhibitoren
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MXPA04006553A (es) Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih.
IL112841A0 (en) Sulfonamide aspartyl protease inhibitors methods for the preparation thereof and pharmaceutical compositions containing the same
ATE252081T1 (de) Neue hiv-protease-inhibitoren
BG100016A (en) Hiv protease inhibitors applicable in the treatment of aids
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
YU172991A (sh) Sinergizam inhibitora hiv reverzne transkriptaze
BR9408305A (pt) Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos
DK1053012T3 (da) Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
IT1318424B1 (it) Composti con attivita' anti-hiv.
DK0774969T3 (da) HIV-proteaseinhibitor kombination
WO2002096359A3 (en) Piperazine pentanamide hiv protease inhibitors
BR0314478A (pt) Derivado de 6-metilpiridina, método para sua preparação e composição farmacêutica contendo o mesmo
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
RU93055683A (ru) Ингибиторы вич-протеазы, способ их получения, их использование, композиция
RU93055680A (ru) Ингибиторы вич-протеазы, способ получения, их использование, композиция
TH14264B (th) ตัวยับยั้ง hiv โพรทิเอส
RU97104066A (ru) Сочетание ингибиторов вич-протеазы